The report reveals that although there is soaring demand for popular weight-loss drugs, commercial insurance coverage for many of these medications has become significantly more restrictive in 2025
Tsakiroglou AM, Fergie M, Oguejiofor K, Linton K, Thomson D, Stern PL, et al
Indirect potency monitoring through outcome tracking is more practical for most researchers
These drugs have transformed from primarily being used to manage diabetes to a widely sought-after tool for metabolic health and weight loss
[On-screen text: How else can CVS help me with my weight-loss journey?] [Cut to Amy Lynn.] Amy Lynn, speaking: It is so important for patients to understand that their pharmacist is there for them to answer any questions that they may have
However, these mechanisms remain partially understood and warrant further clinical investigation